Shi-Qi Zhao1, Zhao Hu2. 1. Emergency Department, Linyi People's Hospital of Shandong University, Linyi, China. 2. Department of Nephrology, Qilu Hospital of Shandong University, Jinan, China.
Abstract
OBJECTIVE: The aim of this study was to investigate serum levels of mannose-binding lectin (MBL) in type 1 diabetes with diabetic nephropathy (DN) and persistent normoalbuminuria (PN). METHOD: Serum MBL levels were determined in 224 type 1 diabetes with overt nephropathy and 224 type 1 diabetes with PN matched for sex, age, and duration of diabetes The prediction value of MBL was compared with hemoglobin A1c (HbA1c), high-sensitivity C-reactive protein (Hs-CRP) and other known predictors. Multivariate analyses were performed using logistic regression models. RESULTS: The serum MBL levels were significantly higher in diabetes with DN as compared to with PN (P < 0.0001). Based on the receiver operating characteristic (ROC) curve, the optimal cutoff value of serum MBL levels as an indicator for diagnosis of DN was projected to be 1,680 μg/l, which yielded a sensitivity of 75.4% and a specificity of 78.8%, with the area under the curve at 0.768 (95% confidence interval [CI], 0.724-0.815). Multivariate logistic regression analysis adjusted for common factors showed that serum MBL level ≥ 1,680 μg/l was an independent indictor of DN (odds ratio [OR] = 6.99; 95% CI: 2.83-17.15). CONCLUSION: In type 1 diabetic patient, evaluated serum levels of MBL can be seen as an independent marker of DN even after correcting for possible confounding factors.
OBJECTIVE: The aim of this study was to investigate serum levels of mannose-binding lectin (MBL) in type 1 diabetes with diabetic nephropathy (DN) and persistent normoalbuminuria (PN). METHOD: Serum MBL levels were determined in 224 type 1 diabetes with overt nephropathy and 224 type 1 diabetes with PN matched for sex, age, and duration of diabetes The prediction value of MBL was compared with hemoglobin A1c (HbA1c), high-sensitivity C-reactive protein (Hs-CRP) and other known predictors. Multivariate analyses were performed using logistic regression models. RESULTS: The serum MBL levels were significantly higher in diabetes with DN as compared to with PN (P < 0.0001). Based on the receiver operating characteristic (ROC) curve, the optimal cutoff value of serum MBL levels as an indicator for diagnosis of DN was projected to be 1,680 μg/l, which yielded a sensitivity of 75.4% and a specificity of 78.8%, with the area under the curve at 0.768 (95% confidence interval [CI], 0.724-0.815). Multivariate logistic regression analysis adjusted for common factors showed that serum MBL level ≥ 1,680 μg/l was an independent indictor of DN (odds ratio [OR] = 6.99; 95% CI: 2.83-17.15). CONCLUSION: In type 1 diabeticpatient, evaluated serum levels of MBL can be seen as an independent marker of DN even after correcting for possible confounding factors.
Authors: M Saraheimo; C Forsblom; T K Hansen; A-M Teppo; J Fagerudd; K Pettersson-Fernholm; S Thiel; L Tarnow; P Ebeling; A Flyvbjerg; P-H Groop Journal: Diabetologia Date: 2004-12-23 Impact factor: 10.122
Authors: A Koch; M Melbye; P Sørensen; P Homøe; H O Madsen; K Mølbak; C H Hansen; L H Andersen; G W Hahn; P Garred Journal: JAMA Date: 2001-03-14 Impact factor: 56.272
Authors: Juan F Navarro-González; Carmen Mora-Fernández; Mercedes Muros de Fuentes; Javier García-Pérez Journal: Nat Rev Nephrol Date: 2011-05-03 Impact factor: 28.314
Authors: Mary C Walsh; Todd Bourcier; Kazue Takahashi; Lei Shi; Marc N Busche; Russell P Rother; Scott D Solomon; R Alan B Ezekowitz; Gregory L Stahl Journal: J Immunol Date: 2005-07-01 Impact factor: 5.422
Authors: Lauren Winter; Lydia A Wong; George Jerums; Jas-Mine Seah; Michele Clarke; Sih Min Tan; Melinda T Coughlan; Richard J MacIsaac; Elif I Ekinci Journal: Front Endocrinol (Lausanne) Date: 2018-05-22 Impact factor: 5.555